Efficacy of abobotulinumtoxinA versus onabotulinumtoxinA for the treatment of refractory neurogenic detrusor overactivity: a systematic review and indirect treatment comparison.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of medical economics"
DOI: 10.1080/13696998.2023.2165366
Abstract: AIMS To compare the efficacy and safety of abobotulinumtoxinA1 (aboBoNT-A) and onabotulinumtoxinA2 (onaBoNT-A) for the treatment of refractory neurogenic detrusor overactivity (NDO), using indirect treatment comparison (ITC). MATERIALS AND METHODS A systematic literature review was… read more here.
Keywords: neurogenic detrusor; treatment refractory; detrusor overactivity; refractory neurogenic ... See more keywords